InvestorNewsBreaks – Roth Capital Partners’ Upcoming Event to Feature Latest Trends in Biotechnology, Pharmaceuticals and Medical Technologies

June 25, 2021 12:07:59

Roth Capital Partners (“Roth”), a relationship-driven investment bank, today announced that it will host the Roth Virtual Healthcare Private Company Forum on June 28, 2021. According to the update, the event will feature virtual panels on emerging therapeutics and select fireside chats with Roth research analysts. The engaging, digital format will enable C-level executives from established private healthcare companies in the biotechnology, pharmaceuticals and medical technologies verticals to share their stories and insight. “We are excited to host our Virtual Healthcare Private Company Forum for private companies. As the event continues to grow, we are bringing together a broader range of private healthcare companies, from across the U.S. and beyond, to tell their stories,” said James Antonopoulos, Roth’s Managing Director and Head of Healthcare Investment Banking. “This event is another example of Roth’s continued leadership in supporting the growth of healthcare companies, including biotechnology, specialty pharmaceuticals, medical devices and diagnostics.”

To view the full press release, visit https://ibn.fm/nXAH6

About Roth Capital Partners, LLC (“Roth”)

Roth is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services, and corporate access. Headquartered in Newport Beach, California, Roth is privately held, employee-owned and maintains offices throughout the U.S. For more information, visit www.roth.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.